First Page | Document Content | |
---|---|---|
Medicine Clinical medicine Cancer Tyrosine kinase receptors Breast cancer Atezolizumab ROS1 Triple-negative breast cancer Anaplastic lymphoma kinase Trastuzumab emtansine Entrectinib Metastatic breast cancer | European Society for Medical Oncology (ESMOCongress Roche Analyst Audio Webcast Monday, 22 October 2018 Welcome Daniel O’Day, CEO Roche PharmaceuticalsAdd to Reading ListSource URL: www.roche.comDownload Document from Source WebsiteFile Size: 2,40 MBShare Document on Facebook |